Cancer Archive — Page 10 of 69
-
November 8, 2024
In-clinic reconstruction of skin cancer defects costs less than OR procedures
Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures. -
November 4, 2024
Tae Kon Kim receives V Foundation grant for MDS drug research
Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS. -
October 31, 2024
Chic Awearness surpasses $1 million for ovarian cancer research and patient support
Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives. -
October 31, 2024
Jeffrey Tosoian named chair of EDRN Prostate/GU Cancer Collaborative
The EDRN works to discover, develop and validate biomarkers and imaging methods to detect early-stage cancers, assess risk for developing cancer, and translate these tools into clinical tests. -
October 30, 2024
Michael Gibson votes with FDA panel to limit immunotherapy indication
The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. -
October 18, 2024
Curbing late-stage breast cancer diagnosis: Innovative mobile diagnostic kit aims to improve early detection in Uganda
An international team of experts, including the Uganda Cancer Institute, is developing a groundbreaking mobile breast cancer diagnostic kit to enhance early detection in Uganda, where 70% of cases are diagnosed at an advanced stage. -
October 15, 2024
Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships
Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.